Biotech Startups
10,023 companies tagged Biotech, with their investors and founders.
0 investors
Lumina Pharmaceuticals is a clinical-stage company that develops diagnostic and therapeutic radiopharmaceuticals using peptide technology.
0 investors
0 investors
Luna Genetics is a clinical genetics company offering prenatal and pre-conception genetic testing and diagnosis, supported by genetic counseling services. It operates a clinical laboratory focused on reproductive and prenatal genetics.
0 investors
0 investors
0 investors
0 investors
Ann Arbor-founded biopharmaceutical company developing small molecule immunomodulators for autoimmune diseases and cancer.
0 investors
Lycia Therapeutics is a biotechnology company developing LYTAC (Lysosomal Targeting Chimera) therapeutics that bind disease-causing extracellular and cell-surface proteins and route them into the cell's lysosome for degradation. Its targeted protein degradation platform, based on research from Carolyn Bertozzi's lab at Stanford, aims to address proteins previously considered undruggable.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Lysosomal Therapeutics Inc. (LTI) develops small-molecule drug therapies for severe neurological diseases affecting movement and cognition, with a lead candidate, LTI-291, targeting GBA-associated parkinsonism, a form of Parkinson's disease linked to GBA1 gene mutations. The company's drug discovery approach draws on the biological link between common neurodegenerative diseases and rare lysosomal genetic disorders.
0 investors
0 investors
0 investors
0 investors
MABE Bio, based in São Paulo, develops plant-derived materials and surface finishes. The company applies biotechnology and materials science to create alternatives to conventional inputs for manufacturers and designers.
0 investors
0 investors
0 investors
0 investors
0 investors
Macrotope engineers protein antigens using its patented MacroAntigen/MAV platform, which tunes antigen conformational dynamics to broaden immune response for vaccine and therapeutic antibody discovery. It develops its own vaccine candidates (including for SARS-CoV-2 and related coronaviruses) and offers antibody discovery services to biopharma partners.
0 investors